Vancomycin-Induced Stevens-Johnson Syndrome in a Boy Under 2 Years Old: An Early Diagnosis by Granulysin Rapid Test

Stevens-Johnson syndrome (SJS) is a life-threatening disease, which is mainly ascribed to drugs, such as sulfonamides and psychoepileptics. In this article, we present a pediatric case of vancomycin-induced SJS and an alternative diagnostic algorithm. The patient presented with multiple target-like rashes and vesicles throughout the whole body after receiving vancomycin. Despite the fact that skin biopsy remains the gold standard for diagnosing SJS, the granulysin rapid test by immunochromatographic assay is a non-invasive option for children. In this article, we describe our use of the Algorithm of Drug causality for Epidermal Necrolysis and a modified T-cell activation assay for granzyme B and interferon gamma to screen for the culprit drug. Moreover, we applied the granulysin rapid test as an early diagnosis method for children with drug-induced SJS.

[1]  Woan‐Ruoh Lee,et al.  Efficacy of cyclosporine for the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: Systemic review and meta-analysis , 2017 .

[2]  Y. Keynan,et al.  Vancomycin Revisited – 60 Years Later , 2014, Front. Public Health.

[3]  C. Wang,et al.  Stevens–Johnson syndrome induced by the cross‐reactivity between teicoplanin and vancomycin , 2014, Journal of clinical pharmacy and therapeutics.

[4]  W. Pichler,et al.  In vitro drug causality assessment in Stevens–Johnson syndrome – alternatives for lymphocyte transformation test , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  H. Shimizu,et al.  Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis. , 2011, Journal of the American Academy of Dermatology.

[6]  Chen-Yang Shen,et al.  Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. , 2011, The New England journal of medicine.

[7]  A. Dunant,et al.  ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis , 2010, Clinical pharmacology and therapeutics.

[8]  H. Shimizu,et al.  Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome. , 2009, Annals of internal medicine.

[9]  A. Flahault,et al.  Medications as Risk Factors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children: A Pooled Analysis , 2009, Pediatrics.

[10]  Yuan-Tsong Chen,et al.  Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis , 2008, Nature Medicine.

[11]  Yuan-Tsong Chen,et al.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Metry,et al.  Use of intravenous immunoglobulin in children with stevens-johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. , 2003, Pediatrics.

[13]  P. Greenberger,et al.  Vancomycin-induced Stevens-Johnson syndrome. , 1996, Allergy and asthma proceedings.

[14]  R. Stern,et al.  Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. , 1996, The New England journal of medicine.

[15]  C. Laurencin,et al.  Stevens-Johnson-Type Reaction with Vancomycin Treatment , 1992, The Annals of pharmacotherapy.